<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://singularityguide.de/news/biohub-entwickelt-ki-modell-fuer-proteindesign-fyiva</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T11:00:26.023+00:00</news:publication_date>
      <news:title>Biohub entwickelt KI-Modell für Proteindesign</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/alzinova-startet-phase-2-studie-fuer-alzheimer-impfstoff-3499r</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T09:00:25.909+00:00</news:publication_date>
      <news:title>Alzinova startet Phase-2-Studie für Alzheimer-Impfstoff</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/epigenetik-gegen-cholesterin-ohne-dna-aenderung-341lx</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T07:00:25.754+00:00</news:publication_date>
      <news:title>Epigenetik gegen Cholesterin ohne DNA-Änderung</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/ki-in-der-krebstherapie-diagnose-ja-heilung-noch-offen-33tej</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T05:00:25.81+00:00</news:publication_date>
      <news:title>KI in der Krebstherapie: Diagnose ja, Heilung noch offen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/calico-und-nexo-entwickeln-wirkstoffe-gegen-altern-l5haj</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-02T15:00:25.732+00:00</news:publication_date>
      <news:title>Calico und Nexo entwickeln Wirkstoffe gegen Altern</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/sensoren-kalibrierung-das-wahre-sehproblem-von-robotern-qaoln</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-02T13:00:26.011+00:00</news:publication_date>
      <news:title>Sensoren-Kalibrierung: Das wahre Sehproblem von Robotern</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/robotics-summit-2026-startet-mit-demos-qago7</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-02T11:00:26.126+00:00</news:publication_date>
      <news:title>Robotics Summit 2026 startet mit Demos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/30-startups-konkurrieren-um-longevity-pitch-preis-q9f9w</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-02T09:00:26.186+00:00</news:publication_date>
      <news:title>30 Startups konkurrieren um Longevity-Pitch-Preis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/harvard-health-legitimiert-longevity-forschung-q98ig</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-02T07:00:25.664+00:00</news:publication_date>
      <news:title>Harvard Health legitimiert Longevity-Forschung</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/perplexity-startet-ki-agent-fuer-automatisierte-aufgaben-q8jra</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-02T05:00:25.758+00:00</news:publication_date>
      <news:title>Perplexity startet KI-Agent für automatisierte Aufgaben</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/seneszente-zellen-gezielt-eliminieren-sutfb</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-01T15:00:25.697+00:00</news:publication_date>
      <news:title>Seneszente Zellen gezielt eliminieren</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/amazon-baut-ki-agenten-zahlungsplattform-fuer-autonome-systeme-xxj6y</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-06-01T13:00:25.598+00:00</news:publication_date>
      <news:title>Amazon baut KI-Agenten-Zahlungsplattform für autonome Systeme</news:title>
    </news:news>
  </url>
</urlset>